{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T17:58:04Z","timestamp":1709575084561},"reference-count":41,"publisher":"American Physiological Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Renal Physiology"],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:p> The tuberous sclerosis-2 ( Tsc-2) gene is a suppressor of renal tumorigenesis and an early target of reactive oxygen species-induced renal cancer. Tuberin, the protein product of the Tsc-2 gene, participates in the regulation of cell proliferation, although the mechanism by which it suppresses proliferation is unknown. Quinol-thioether-transformed rat renal epithelial (QT-RRE) cell lines, derived from quinol-thioether-transformed primary renal epithelial cells from Eker rats, lack tuberin expression due to loss of heterozygosity of the Tsc-2 gene. These cell lines were used to examine the mechanism by which tuberin exerts its antiproliferative action. Loss of tuberin function correlates with high ERK activity ( 39 ), which could contribute to the formation of renal tumors. In this study, we sought to identify possible downstream effectors regulated by tuberin, using QT-RRE cells transfected with Tsc-2 cDNA to restore tuberin expression. Constitutively high ERK, B-Raf, and Raf-1 activities were observed in QT-RRE cells. However, restoration of tuberin expression in QT-RRE cells by transient transfection with Tsc-2 cDNA substantially decreased both ERK and B-Raf activity, with only modest changes in Raf-1 activity, suggesting tuberin functions as an upstream negative regulator of the ERK pathway. High ERK activity was not mediated through EGF receptor activation, but treatment with genistein demonstrated that protein kinases are involved in ERK cascade activation. The data indicate that loss of tuberin results in the upregulation of the ERK signaling pathway with subsequent increases in new DNA synthesis, and ultimately, tumor formation. <\/jats:p>","DOI":"10.1152\/ajprenal.00234.2003","type":"journal-article","created":{"date-parts":[[2004,1,31]],"date-time":"2004-01-31T01:13:21Z","timestamp":1075511601000},"page":"F417-F424","source":"Crossref","is-referenced-by-count":13,"title":["Tuberous sclerosis-2 tumor suppressor modulates ERK and B-Raf activity in transformed renal epithelial cells"],"prefix":"10.1152","volume":"286","author":[{"given":"Hae-Seong","family":"Yoon","sequence":"first","affiliation":[{"name":"Center for Molecular and Cellular Toxicology, Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Texas 78712"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sampath","family":"Ramachandiran","sequence":"additional","affiliation":[{"name":"Center for Molecular and Cellular Toxicology, Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Texas 78712"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Anne S.","family":"Chacko","sequence":"additional","affiliation":[{"name":"Center for Molecular and Cellular Toxicology, Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Texas 78712"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence J.","family":"Monks","sequence":"additional","affiliation":[{"name":"Center for Molecular and Cellular Toxicology, Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Texas 78712"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serrine S.","family":"Lau","sequence":"additional","affiliation":[{"name":"Center for Molecular and Cellular Toxicology, Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Texas 78712"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","reference":[{"key":"REF1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204009"},{"key":"REF2","doi-asserted-by":"publisher","DOI":"10.1016\/0968-0004(94)90133-3"},{"key":"REF3","doi-asserted-by":"publisher","DOI":"10.1007\/s004280050350"},{"key":"REF4","doi-asserted-by":"crossref","unstructured":"Hara I, Miyake H, Hara S, Arakawa S, and Kamidono S. Sodium butyrate induces apoptosis in human renal cell carcinoma cells and synergistically enhances their sensitivity to anti-Fas-mediated cytotoxicity. Int J Oncol 17: 1213-1218, 2000.","DOI":"10.3892\/ijo.17.6.1213"},{"key":"REF5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202367"},{"key":"REF6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.1.156"},{"key":"REF7","doi-asserted-by":"publisher","DOI":"10.1038\/ncb839"},{"key":"REF8","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80657-1"},{"key":"REF9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.17.9154"},{"key":"REF10","doi-asserted-by":"publisher","DOI":"10.1007\/s003359900502"},{"key":"REF11","doi-asserted-by":"publisher","DOI":"10.1021\/tx000161g"},{"key":"REF12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.34.20608"},{"key":"REF13","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/21.12.2167"},{"key":"REF14","doi-asserted-by":"publisher","DOI":"10.1126\/science.8052857"},{"key":"REF15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.7.4378"},{"key":"REF16","doi-asserted-by":"publisher","DOI":"10.1038\/383127a0"},{"key":"REF17","doi-asserted-by":"publisher","DOI":"10.1016\/0959-437X(94)90095-7"},{"key":"REF18","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90401-8"},{"key":"REF19","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(97)80060-9"},{"key":"REF20","doi-asserted-by":"publisher","DOI":"10.1038\/375554a0"},{"key":"REF21","unstructured":"Oka H, Chatani Y, Hoshino R, Ogawa O, Kakehi Y, Terachi T, Okada Y, Kawaichi M, Kohno M, and Yoshida O. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 55: 4182-4187, 1995."},{"key":"REF22","unstructured":"Okazaki K and Sagata N. MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos. Oncogene 10: 1149-1157, 1995."},{"key":"REF23","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.0183"},{"key":"REF24","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00333-6"},{"key":"REF25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.46.29301"},{"key":"REF26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.26.15653"},{"key":"REF27","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00332-4"},{"key":"REF28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.202476899"},{"key":"REF29","unstructured":"Troppmair J, Bruder JT, App H, Cai H, Liptak L, Szeberenyi J, Cooper GM, and Rapp UR. Ras controls coupling of growth factor receptors and protein kinase C in the membrane to Raf-1 and B-Raf protein serine kinases in the cytosol. Oncogene 7: 1867-1873, 1992."},{"key":"REF30","unstructured":"Tsuchiya H, Orimoto K, Kobayashi K, and Hino O. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model. Cancer Res 56: 429-433, 1996."},{"key":"REF31","doi-asserted-by":"publisher","DOI":"10.1021\/bi00233a001"},{"key":"REF32","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80184-1"},{"key":"REF33","doi-asserted-by":"publisher","DOI":"10.1177\/019262339802600113"},{"key":"REF34","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0766fje"},{"key":"REF35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.27.16409"},{"key":"REF36","unstructured":"Wienecke R, Maize JC Jr, Reed JA, de Gunzburg J, Yeung RS, and DeClue JE. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am J Pathol 150: 43-50, 1997."},{"key":"REF37","unstructured":"Wienecke R, Maize JC Jr, Shoarinejad F, Vass WC, Reed J, Bonifacino JS, Resau JH, de Gunzburg J, Yeung RS, and DeClue JE. Colocalization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene 13: 913-923, 1996."},{"key":"REF38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.10.6097"},{"key":"REF39","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00261.2001"},{"key":"REF40","doi-asserted-by":"publisher","DOI":"10.1002\/mc.1037"},{"key":"REF41","doi-asserted-by":"publisher","DOI":"10.1038\/33451"}],"container-title":["American Journal of Physiology-Renal Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajprenal.00234.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T21:35:05Z","timestamp":1567978505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajprenal.00234.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["10.1152\/ajprenal.00234.2003"],"URL":"https:\/\/doi.org\/10.1152\/ajprenal.00234.2003","relation":{},"ISSN":["1931-857X","1522-1466"],"issn-type":[{"value":"1931-857X","type":"print"},{"value":"1522-1466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}